vs
Side-by-side financial comparison of AVANOS MEDICAL, INC. (AVNS) and Bandwidth Inc. (BAND). Click either name above to swap in a different company.
Bandwidth Inc. is the larger business by last-quarter revenue ($208.8M vs $180.9M, roughly 1.2× AVANOS MEDICAL, INC.). Bandwidth Inc. runs the higher net margin — 1.9% vs -0.7%, a 2.6% gap on every dollar of revenue. On growth, Bandwidth Inc. posted the faster year-over-year revenue change (20.1% vs 0.7%). AVANOS MEDICAL, INC. produced more free cash flow last quarter ($21.3M vs $-1.0M). Over the past eight quarters, Bandwidth Inc.'s revenue compounded faster (9.7% CAGR vs 4.4%).
Avanos Medical, Inc. is a medical technology company making clinical medical devices. The company consists of two franchises – Pain Management and Chronic Care – that address reducing the use of opioids while helping patients recover faster and preventing infection.
Bandwidth Inc. is a communications platform as a service company. It sells software application programming interfaces for voice, text messaging and emergency services, using its own global IP voice network.
AVNS vs BAND — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $180.9M | $208.8M |
| Net Profit | $-1.3M | $4.0M |
| Gross Margin | 47.5% | 37.3% |
| Operating Margin | 1.4% | 60.5% |
| Net Margin | -0.7% | 1.9% |
| Revenue YoY | 0.7% | 20.1% |
| Net Profit YoY | 99.7% | 200.0% |
| EPS (diluted) | $-0.02 | $-0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $208.8M | ||
| Q4 25 | $180.9M | $207.7M | ||
| Q3 25 | $177.8M | $191.9M | ||
| Q2 25 | $175.0M | $180.0M | ||
| Q1 25 | $167.5M | $174.2M | ||
| Q4 24 | $179.6M | $210.0M | ||
| Q3 24 | $170.4M | $193.9M | ||
| Q2 24 | $171.7M | $173.6M |
| Q1 26 | — | $4.0M | ||
| Q4 25 | $-1.3M | — | ||
| Q3 25 | $-1.4M | $-1.2M | ||
| Q2 25 | $-76.8M | $-4.9M | ||
| Q1 25 | $6.6M | $-3.7M | ||
| Q4 24 | $-397.3M | — | ||
| Q3 24 | $4.3M | $413.0K | ||
| Q2 24 | $1.8M | $4.1M |
| Q1 26 | — | 37.3% | ||
| Q4 25 | 47.5% | 37.6% | ||
| Q3 25 | 48.4% | 38.5% | ||
| Q2 25 | 52.6% | 39.8% | ||
| Q1 25 | 53.6% | 41.0% | ||
| Q4 24 | 54.6% | 36.4% | ||
| Q3 24 | 54.5% | 37.7% | ||
| Q2 24 | 55.7% | 37.3% |
| Q1 26 | — | 60.5% | ||
| Q4 25 | 1.4% | -1.9% | ||
| Q3 25 | 0.1% | -1.0% | ||
| Q2 25 | -42.6% | -2.1% | ||
| Q1 25 | 6.1% | -2.7% | ||
| Q4 24 | -233.0% | -1.3% | ||
| Q3 24 | 7.0% | -0.5% | ||
| Q2 24 | 3.7% | -3.5% |
| Q1 26 | — | 1.9% | ||
| Q4 25 | -0.7% | — | ||
| Q3 25 | -0.8% | -0.6% | ||
| Q2 25 | -43.9% | -2.7% | ||
| Q1 25 | 3.9% | -2.1% | ||
| Q4 24 | -221.2% | — | ||
| Q3 24 | 2.5% | 0.2% | ||
| Q2 24 | 1.0% | 2.3% |
| Q1 26 | — | $-0.08 | ||
| Q4 25 | $-0.02 | $-0.10 | ||
| Q3 25 | $-0.03 | $-0.04 | ||
| Q2 25 | $-1.66 | $-0.16 | ||
| Q1 25 | $0.14 | $-0.13 | ||
| Q4 24 | $-8.64 | $0.27 | ||
| Q3 24 | $0.09 | $0.01 | ||
| Q2 24 | $0.04 | $-0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.8M | $47.3M |
| Total DebtLower is stronger | $90.3M | — |
| Stockholders' EquityBook value | $778.2M | $405.7M |
| Total Assets | $1.1B | $984.2M |
| Debt / EquityLower = less leverage | 0.12× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $47.3M | ||
| Q4 25 | $89.8M | $111.3M | ||
| Q3 25 | $70.5M | $80.4M | ||
| Q2 25 | $90.3M | $68.1M | ||
| Q1 25 | $97.0M | $41.7M | ||
| Q4 24 | $107.7M | $83.8M | ||
| Q3 24 | $89.0M | $79.9M | ||
| Q2 24 | $92.2M | $76.4M |
| Q1 26 | — | — | ||
| Q4 25 | $90.3M | — | ||
| Q3 25 | $93.4M | — | ||
| Q2 25 | $95.7M | — | ||
| Q1 25 | $98.0M | — | ||
| Q4 24 | $125.3M | — | ||
| Q3 24 | $152.6M | — | ||
| Q2 24 | $164.9M | — |
| Q1 26 | — | $405.7M | ||
| Q4 25 | $778.2M | $400.0M | ||
| Q3 25 | $778.0M | $392.7M | ||
| Q2 25 | $776.3M | $384.5M | ||
| Q1 25 | $839.4M | $345.4M | ||
| Q4 24 | $828.5M | $312.5M | ||
| Q3 24 | $1.2B | $336.6M | ||
| Q2 24 | $1.2B | $307.4M |
| Q1 26 | — | $984.2M | ||
| Q4 25 | $1.1B | $1.1B | ||
| Q3 25 | $1.1B | $1.0B | ||
| Q2 25 | $1.0B | $1.0B | ||
| Q1 25 | $1.1B | $964.4M | ||
| Q4 24 | $1.2B | $989.2M | ||
| Q3 24 | $1.7B | $1.0B | ||
| Q2 24 | $1.7B | $1.0B |
| Q1 26 | — | — | ||
| Q4 25 | 0.12× | — | ||
| Q3 25 | 0.12× | — | ||
| Q2 25 | 0.12× | — | ||
| Q1 25 | 0.12× | — | ||
| Q4 24 | 0.15× | — | ||
| Q3 24 | 0.12× | — | ||
| Q2 24 | 0.13× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.2M | — |
| Free Cash FlowOCF − Capex | $21.3M | $-1.0M |
| FCF MarginFCF / Revenue | 11.8% | -0.5% |
| Capex IntensityCapex / Revenue | 3.8% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $43.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $28.2M | $38.6M | ||
| Q3 25 | $14.0M | $22.2M | ||
| Q2 25 | $6.8M | $31.7M | ||
| Q1 25 | $25.7M | $-3.1M | ||
| Q4 24 | $57.9M | $36.5M | ||
| Q3 24 | $23.0M | $20.5M | ||
| Q2 24 | $27.8M | $24.4M |
| Q1 26 | — | $-1.0M | ||
| Q4 25 | $21.3M | — | ||
| Q3 25 | $7.0M | — | ||
| Q2 25 | $-4.2M | — | ||
| Q1 25 | $19.0M | — | ||
| Q4 24 | $53.1M | — | ||
| Q3 24 | $20.0M | — | ||
| Q2 24 | $21.9M | — |
| Q1 26 | — | -0.5% | ||
| Q4 25 | 11.8% | — | ||
| Q3 25 | 3.9% | — | ||
| Q2 25 | -2.4% | — | ||
| Q1 25 | 11.3% | — | ||
| Q4 24 | 29.6% | — | ||
| Q3 24 | 11.7% | — | ||
| Q2 24 | 12.8% | — |
| Q1 26 | — | — | ||
| Q4 25 | 3.8% | — | ||
| Q3 25 | 3.9% | — | ||
| Q2 25 | 6.3% | — | ||
| Q1 25 | 4.0% | — | ||
| Q4 24 | 2.7% | — | ||
| Q3 24 | 1.8% | — | ||
| Q2 24 | 3.4% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.89× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.35× | 49.55× | ||
| Q2 24 | 15.44× | 6.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVNS
| Enteral Feeding | $83.0M | 46% |
| Radiofrequency Ablation | $36.9M | 20% |
| Neonate Solutions | $32.1M | 18% |
| Surgical Pain And Recovery | $24.7M | 14% |
| Corporate Other | $4.2M | 2% |
BAND
Segment breakdown not available.
